Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03848650 · ClinicalTrials.gov registry record · NA
The Drift-Reduction for Improved FFR Using Fiberoptic Technology (DRIFT) Study
A NA study, sponsored by Columbia University.
- Completed
- Registry status
- NA
- Development phase
- 60
- Enrollment target
NCT03848650 is a NA study that has completed, run by Columbia University. The registered enrollment target is 60 participants.
The verdict
NCT03848650, a NA study, has completed, sponsored by Columbia University.
- COMPLETED
- Registry status
- NA
- Development phase
- 60 participants
- Enrollment target
Study Summary
The primary objective of this study is to assess the accuracy, efficacy, and durability of the OpSens Medical OptoWire Deux pressure wire in the assessment of angiographically intermediate proximal left anterior descending coronary artery (LAD) stenoses in clinical practice.
Interventions
- DEVICE OpSens Medical OptoWire
- PROCEDURE FFR
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2018-06-19 |
| Est. Completion | 2019-05-13 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03848650
The ClinicalTrials.gov registry entry for NCT03848650 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Columbia University, which has 958 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which OpSens Medical OptoWire is the first listed.
NCT03848650 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03848650 about?
NCT03848650 is a clinical study titled "The Drift-Reduction for Improved FFR Using Fiberoptic Technology (DRIFT) Study". The primary objective of this study is to assess the accuracy, efficacy, and durability of the OpSens Medical OptoWire Deux pressure wire in the assessment of angiographically intermediate proximal left anterior descending coronary artery (LAD) stenoses in clinical practice.
What is the current status of trial NCT03848650?
This trial is currently completed. It is a NA study. The enrollment target is 60 participants. The study started on 2018-06-19. Estimated completion is 2019-05-13.
What interventions are being tested in trial NCT03848650?
The interventions under investigation include: OpSens Medical OptoWire (DEVICE), FFR (PROCEDURE).
Who is sponsoring clinical trial NCT03848650?
This trial is sponsored by Columbia University, which has 958 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.